Experienced in Chorea

Wei J. Yi

No. 5 Yiheyuan Road, 
Haidian, CN 
Experienced in Chorea
No. 5 Yiheyuan Road, 
Haidian, CN 
OverviewLocationsClinical Research

Overview

Wei Yi practices in Haidian, China. Yi is rated as an Experienced expert by MediFind in the treatment of Chorea. Their top areas of expertise are Hand-Foot-Mouth Disease (HFMD), Hepatitis B, Hepatitis, Nasopharyngeal Carcinoma, and Deep Brain Stimulation.

Their clinical research consists of co-authoring 518 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Chorea.

Locations

No. 5 Yiheyuan Road, Haidian, 100871, China
Other Locations
127 Changle West Road, Xi'an, 710032, China
238 Jiefang Road, Wuhan, 430060, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine With the Omission of Immune Globulin to Prevent Hepatitis B Transmission in Mother With High Viral Load: A Multi-Center, Prospective, Randomized and Open-Label Study
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine With the Omission of Immune Globulin to Prevent Hepatitis B Transmission in Mother With High Viral Load: A Multi-Center, Prospective, Randomized and Open-Label Study
Enrollment Status: Unknown
Publish Date: December 12, 2019
Intervention Type: Drug
Study Drug: Tenofovir Disoproxil Fumarate 
Study Phase: Phase 4

518 Total Publications

N-[3-(4-(2-methoxyphenyl) piperazine-1-yl) propyl]-heteroaromatic carboxamide as selective α1A/1D-adrenoceptor antagonists: SAR study and metabolic stability evaluation.
N-[3-(4-(2-methoxyphenyl) piperazine-1-yl) propyl]-heteroaromatic carboxamide as selective α1A/1D-adrenoceptor antagonists: SAR study and metabolic stability evaluation.
Journal: Bioorganic & medicinal chemistry letters
Published: October 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yi's expertise for a condition
ConditionClose
    View All 71 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile